Table 1 shows the characteristics of each agent and the consequences of NDRG1. In studies of these agents, it has been considered that NDRG1 could be the target of an agent, alter its expression, and be involved in mechanisms of efficiency in GBM cells [11,29,70,71,72,73,74]. Figure 4 shows the relationship between agents reported previously and NDRG1. The gene discussed is NDRG1; the disease is glioblastoma.